您的购物车当前为空
别名 普拉克索, SND 919
Pramipexole (SND 919) 是能够透过血脑屏障的 D2 型多巴胺受体的选择性激动剂,对 D2 型受体、D2、D3、D4亚型受体的Ki 分别为 2.2 nM、3.9 nM、0.5 nM、1.3 nM。它可用于研究帕金森综合症和腿多动综合征。

Pramipexole (SND 919) 是能够透过血脑屏障的 D2 型多巴胺受体的选择性激动剂,对 D2 型受体、D2、D3、D4亚型受体的Ki 分别为 2.2 nM、3.9 nM、0.5 nM、1.3 nM。它可用于研究帕金森综合症和腿多动综合征。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 50 mg | ¥ 145 | In stock | |
| 100 mg | ¥ 192 | In stock | |
| 500 mg | ¥ 415 | In stock | |
| 1 g | ¥ 597 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 356 | In stock |
Pramipexole 相关产品
| 产品描述 | Pramipexole (SND 919) is a selective dopamine receptor agonist used in the therapy of Parkinson disease. Pramipexole therapy is associated with a low rate of transient serum enzyme elevations during treatment but has not been implicated in cases of clinically apparent acute liver injury. |
| 靶点活性 | D3 receptor:0.5 nM(Ki), D2S receptor:3.9 nM(Ki), D2L receptor:2.2 nM(Ki), D4 receptor:5.1 nM(Ki) |
| 别名 | 普拉克索, SND 919 |
| 分子量 | 211.33 |
| 分子式 | C10H17N3S |
| CAS No. | 104632-26-0 |
| Smiles | CCCN[C@H]1CCc2c(C1)sc(N)n2 |
| 密度 | 1.17 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 75 mg/mL (354.9 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble or slightly soluble) Ethanol: 39 mg/mL (184.55 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (9.46 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容